EP Patent

EP1813275A1 — Lansoprazole orally disintegrating tablets

Assigned to Teva Pharmaceutical Industries Ltd · Expires 2007-08-01 · 19y expired

What this patent protects

The invention provides orally disintegrating tablets that readily disintegrates in the mouth, releasing enteric coated drug sub-tablets.

USPTO Abstract

The invention provides orally disintegrating tablets that readily disintegrates in the mouth, releasing enteric coated drug sub-tablets.

Drugs covered by this patent

Patent Metadata

Patent number
EP1813275A1
Jurisdiction
EP
Classification
—
Expires
2007-08-01
Drug substance claim
No
Drug product claim
No
Assignee
Teva Pharmaceutical Industries Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.